By: Sofia Bochoidze For millions of people living with Type 1 diabetes, daily life is shaped by constant calculation: glucose ...

Scientists long ago identified their target: a smooth-surfaced protein inside cells, called KRAS, that is altered in certain ...

In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.

A targeted drug-delivery system called TAMP aims to send chemotherapy near pancreatic tumors instead of through the entire ...

A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those ...

Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...

The TFDA approval process included a detailed review of the company’s clinical and regulatory submission package and ...

Common cancers, like breast, skin, and lung cancers, have become far more survivable in recent years, but not pancreatic cancer. That is changing, though, thanks to very recent breakthroughs. NPR's ...

A protein best known for driving cancer growth also helps damaged tumor cells survive by repairing their DNA, according to a ...

Scientists have uncovered a surprising new trick used by one of cancer’s most notorious proteins. MYC, already infamous for ...